Planning for pre-exposure prophylaxis to prevent HIV transmission: challenges and opportunities.

Journal of the International AIDS Society
Susan C KimMark R Dybul

Abstract

There are currently several ongoing or planned trials evaluating the efficacy of pre-exposure prophylaxis (PrEP) as a preventative approach to reducing the transmission of HIV. PrEP may prove ineffective, demonstrate partial efficacy, or show high efficacy and have the potential to reduce HIV infection in a significant way. However, in addition to the trial results, it is important that issues related to delivery, implementation and further research are also discussed. As a part of the ongoing discussion, in June 2009, the Bill & Melinda Gates Foundation sponsored a Planning for PrEP conference with stakeholders to review expected trial results, outline responsible educational approaches, and develop potential delivery and implementation strategies. The conference reinforced the need for continued and sustained dialogue to identify where PrEP implementation may fit best within an integrated HIV prevention package. This paper identifies the key action points that emerged from the Planning for PrEP meeting.

References

Aug 15, 2006·JAMA : the Journal of the American Medical Association·Rebecca BunnellKevin M De Cock
Jul 10, 2007·Lancet·John ImrieGraham J Hart
Jul 10, 2007·Lancet·Lynn A PaxtonHarold W Jaffe
Jan 10, 2008·PloS One·Jairam R LingappaUNKNOWN Partners in Prevention HSV-2/HIV Transmission Study Group
Apr 26, 2008·BMJ : British Medical Journal·Gordon H GuyattUNKNOWN GRADE Working Group
Jun 27, 2008·Cornea·Louis TongRoger Beuerman
Jul 17, 2008·Current HIV/AIDS Reports·Kavita P BhavanEdgar Turner Overton

❮ Previous
Next ❯

Citations

Feb 19, 2011·AIDS and Behavior·Susan P Buchbinder, Albert Liu
Mar 15, 2012·Current HIV/AIDS Reports·Kathryn CurranConnie Celum
Apr 14, 2012·Current Opinion in HIV and AIDS·Steffanie A StrathdeeUNKNOWN Substance Use Scientific Committee of the HIV Prevention Trials Network
Jul 27, 2011·Antimicrobial Agents and Chemotherapy·Victoire de LastoursJean-Michel Molina
Apr 16, 2011·American Journal of Public Health·Arleen A LeibowitzMary Jane Rotheram-Borus
Aug 1, 2014·Artificial Cells, Nanomedicine, and Biotechnology·Wenya YuJinkou Zhao
Mar 19, 2014·Human Vaccines & Immunotherapeutics·Jean-Louis ExclerJerome H Kim
Jun 24, 2015·Vaccine·Jean-Louis ExclerJerome H Kim
Nov 23, 2015·American Journal of Preventive Medicine·Jean-Louis ExclerJerome H Kim
Jan 1, 2013·Vaccines·Punnee PitisuttithumJean-Louis Excler
Apr 11, 2018·Journal of Empirical Research on Human Research Ethics : JERHRE·Zaynab Essack, Douglas R Wassenaar
Jul 19, 2011·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Beryl A KoblinUNKNOWN Project MIX Study Team
Aug 23, 2011·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Iryna B ZablotskaAndrew E Grulich
Jan 1, 2014·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Heather A PinesMichael Plankey
Oct 21, 2016·Journal of the International AIDS Society·Jessica B McGillenTimothy B Hallett

❮ Previous
Next ❯

Methods Mentioned

BETA
circumcision

Related Concepts

Related Feeds

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimalarial Agents (ASM)

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Addiction

This feed focuses mechanisms underlying addiction and addictive behaviour including heroin and opium dependence, alcohol intoxication, gambling, and tobacco addiction.

Antitubercular Agents (ASM)

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Antitubercular Agents

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.